General pathophysiological consequences of
angiotensin II (Ang II ) and oxidized low-density lipoenhanced oxidative stress for vascular and renal protein (OxLDL) in the context of oxidative stress and function present a hypothesis on a potential interaction between Ang II and OxLDL. Reactive oxygen species are produced continuously in many, not only vascular or renal, tissues and are part of the unspecific defence system. However, in various Specific effects of Ang II and OxLDL vascular or renal diseases enhanced formation of reactive oxygen species is thought to be pathogenic, e.g. in Evidence for enhanced oxidative stress induced by Ang II atherosclerosis, glomerular disease, renal failure, pyeloCell culture studies with rat smooth muscle cell prenephritis or aminoglycoside nephropathy [1] [2] [3] [4] . In the parations provided the first experimental evidence for vascular system, the formation of O− 2 from endothelial stimulation of O− 2 production by Ang II [17] . In a cells, smooth muscle cells and macrophages seems to more recent investigation, a constitutive O− 2 generating be of major relevance [3] mainly due to its reaction activity was localized in the rabbit aortic adventitia with nitric oxide (NO), particularly in the setting of [18] . This constitutive O− 2 production could be hypercholesterolaemia and atherosclerosis [5] . NO, the enhanced by Ang II, confirming the first study. In the most important endothelium-derived relaxing factor, kidney, Ang II stimulates O− 2 production in cultured is scavenged by O− 2 [6, 7] . NO reacts with O− 2 to yield LLC-PK1, mouse tubule cells [14] and mesangial cells peroxynitrite (ONOO−), which is rather stable but can [16 ] . In addition, increased peroxide formation in rearrange to form nitrate and the highly reactive OHΩ macrophages was demonstrated after stimulation with radical. Important pathophysiological consequences of Ang II via the AT 1 receptor [19] . enhanced oxygen radical formation for the vascular system are: (i) attenuation of the endotheliumdependent dilation, resulting in disturbed organ perfu-Mechanism of Ang II-induced O− 2 production sion and systemic hypertension [8] ; (ii) production of In experiments with rat smooth muscle cell membranes, OHΩ radicals, which cause cellular damage and may Ang II-induced stimulation of O− 2 production could contribute to inflammation [9] ; and (iii) induction of be inhibited by diphenylene iodinium, suggesting that apoptosis [10, 11] stress has been investigated in the context of vasomotor (HUVEC ) and of isolated arteries with oxidized LDL or lipoprotein(a) [Lp(a)] stimulated O− 2 production tone and cell-cycle regulation. In a rat model of Ang II-induced hypertension, it has been shown that vascu- ( Fig. 1) [10, 15, 27, 28] . Induction of free radical formation has also been demonstrated in Lp(a)-lar O− 2 production was enhanced after Ang II treatment, but not after treatment with the control stimulated macrophages [29] and in OxLDL-stimuvasoconstrictor norepinephrine [20] . Enhanced O− 2 lated mesangial cells [30] . production resulted in impairment of endotheliumdependent dilation [21] . This could be prevented by liposome-encapsulated superoxide dismutase (SOD). Mechanism of OxLDL-induced O− 2 production The AT 1 -receptor antagonist losartan also prevented The mechanism through which O− 2 production is impairment of endothelium-dependent dilation, demstimulated has still to be elucidated in detail. Generally, onstrating that the AT 1 receptor was involved. In the oxidation of LDL is a prerequisite for the ability of rat two kidney-one clip model of hypertension, similar LDL to stimulate O− 2 production. This observation results were obtained [22] . In that study, endothelial points to a role of products of the lipid peroxidation cell dysfunction was improved by pre-incubation of process. There is also evidence that specific receptors vascular tissue with SOD and calphostin C, indicating for OxLDL are involved which are distinct from the that increased vascular O− 2 production was secondary classic ApoB100 receptor for native LDL. During to a protein kinase C (PKC )-mediated activation of a lipoprotein oxidation, various products are formed membrane-associated NAD(P)H-dependent oxidase.
which are more or less stable, including lysophosphatiIndirect evidence that Ang II-induced O− 2 production dylcholine, aldehydic lipid peroxidation products, and takes place in vivo in humans was provided by a study fatty acids produced by phospholipase A These comprise the impact of OxLDL-induced producmuscle cells: inhibition of p22(phox) mRNA exprestion of oxygen radicals on: (i) regulation of vascular sion in vascular smooth muscle cells interfered with tone, (ii) renin release and (iii) apoptotic cell death. Ang II-stimulated processes, i.e. (i) NADH/NADPH-O− 2 interacts with NO, resulting in its inactivation [6 ] . dependent superoxide production, (ii) subsequent Through inactivation of NO, OxLDL affects endothelhydrogen peroxide production, and (iii) [3H ]-leucine ial function and impairs endothelium-dependent dilaincorporation [24] .
tion [27, 28, 35] . The latter is an important factor in the Thus, Ang II-induced O− 2 production has important genesis of disturbed organ perfusion, e.g. in the coronconsequences for the regulation of vascular tone and ary circulation [35] . The impact of OxLDL on apopcell cycle.
totic cell death provides another potentially important pathway in the development of atherosclerosis and glomerulosclerosis. OxLDL induces apoptosis in culEvidence for enhanced oxidative stress induced by tured HUVEC ( Fig. 2) [10, 11, 36 ] and in smooth OxLDL muscle cells of isolated aorta [10] . Furthermore, OxLDL induces apoptosis in cultured mouse mesangial Animal studies with cholesterol-fed rabbits provided indirect evidence for a role of low-density lipoprotein cells [30] . In all the cited studies the use of antioxidants (SOD, vitamin C/E, or butylated hydroxytoluene) pre-(LDL) in the induction of oxidative stress. Aortas from hypercholesterolaemic rabbits produced signific-vented apoptosis. Another renal effect was documented in isolated juxtaglomerular cells in primary culture: antly more superoxide than control aortas [25, 26 ] . Later, our group provided direct evidence that incuba-OxLDL stimulated renin release and this effect was linked to stimulation of O− 2 production [15,37]. tion of cultured human umbilical vein endothelial cells 
$
Ang II and OxLDL co-localize in macrophages in the atherosclerotic plaque [38] $ two clinical studies suggest that angiotensinconverting enzyme (ACE) inhibitors are of particular benefit for endothelial function in hypercholesterolemic patients [39, 40] $ the expression of the two receptors, i.e. the OxLDL receptor LOX-1 and the AT 1 receptor, is stimulated by the respective other receptor agonist [41] [42] [43] .
Co-localization of OxLDL and Ang II
Accumulation of OxLDL in atherosclerotic plaques and in the glomerulus is well known and may play an important role in the development of atherosclerosis and glomerulosclerosis [44] [45] [46] [47] . As shown recently, the concentration of Ang II is increased in atherosclerotic arteries, e.g. in human atherectomy preparations and the arteries of hypercholesterolaemic monkeys. Ang II co-localizes with OxLDL in resident macrophages [38] . 
Clinical studies

Potential interaction between Ang II and OxLDL
Animal studies indicated that ACE inhibition is beneficial for endothelial function in hypercholesterolaemia [48] . Two multicentre, prospective, controlled studies Rationale for a potential interaction between Ang II and OxLDL investigated the effect of the ACE inhibitor quinaprilat on endothelial function in humans ( TREND=trial on We propose that Ang II and OxLDL interact in the reversal of endothelial dysfunction and QUIET=quin-context of oxidative stress. This may be of pathophysi-april ischemic event trial [39, 49] ). Subgroup analysis ological relevance, particularly in the genesis of endo-in both studies revealed that the beneficial effect of thelial cell dysfunction. This proposal is based on the ACE inhibition on endothelial cell function was parfollowing considerations:
ticularly pronounced in patients with high serum LDL cholesterol (>125 mg/dl ). This observation is consist- 
